Phase 3
N=554
Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects
Surgery
Bottom Line
View on ClinicalTrials.gov: NCT02222896 ↗Enrolled (actual)
554
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Percent Responder Rates (%) of Bacterial Reduction on the Abdomen and Groin — 93; 86; 50; 25 Percent of Sites
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Chlorhexidine Gluconate (Drug); Vehicle (Other); DynaHex-2 (Drug)
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- All
- Sponsor
- Medline Industries
- Primary completion
- Nov 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Responder Rates (%) of Bacterial Reduction on the Abdomen and Groin |
93; 86; 50; 25; 85; 65 | — |
Summary
Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.
Eligibility Criteria
Inclusion Criteria
- Males or Females
- 16 years of age or older
- Signed informed consent
- Good Health
- Six inches of abdomen and groin areas without tattoos, or skin disorders
Exclusion Criteria
- Dermatological Conditions
- Sensitivity to latex
- Sensitivity to CHG
Data sourced from ClinicalTrials.gov (NCT02222896). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.